Insulin therapy for the treatment of type 1 diabetes during pregnancy

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 27, Issue 12, 2014, Pages 1270-1275

  Lenhard, M James ^a   Kinsley, Brendan T ^b,c  

^a CHRISTIANA CARE HEALTH SYSTEM   (United States)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Glucose monitoring; Glycemic targets; Hypoglycemia; Insulin analogs; Pregnancy

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN ASPART; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN GLULISINE; INSULIN LISPRO; ISOPHANE INSULIN; PIG INSULIN; GLUCOSE BLOOD LEVEL; INSULIN;

BLOOD GLUCOSE MONITORING; DIABETIC KETOACIDOSIS; DISEASE SEVERITY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HELLP SYNDROME; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPOGLYCEMIA; INFANT MORTALITY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TREATMENT; MACROSOMIA; MATERNAL HYPERTENSION; NEWBORN MORBIDITY; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREGNANT WOMAN; PRENATAL CARE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; ANALOGS AND DERIVATIVES; BLOOD; DIABETES MELLITUS, TYPE 1; FEMALE; METABOLISM; PREGNANCY; PREGNANCY IN DIABETICS;

BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; INSULIN; PREGNANCY; PREGNANCY IN DIABETICS;

EID: 84903973808     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2013.864631     Document Type: Review

References (33)

1. Hanson U, Persson B, Thunell S. Relationship between haemoglobin A1C in early type 1 (insulin-dependent) diabetic pregnancy and the occurrence of spontaneous abortion and fetal malformation in Sweden. Diabetologia 1990;33:100-4.
2. Vargas R, Repke JT, Ural SH. Type 1 diabetes mellitus and pregnancy. Rev Obstetr Gynecol 2010;3:92-100.
3. Montoro MN. Diabetic ketoacidosis in pregnancy. In: Reece EA, Coustan DR, Gabbe SG, eds. Diabetes in women: adolescence, pregnancy, and menopause. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2004:345-50.
4. Holmes VA, Young IS, Patterson CC, et al. Optimal glycemic control, pre-eclampsia, and gestational hypertension in women with type 1 diabetes in the diabetes and pre-eclampsia intervention trial. Diabet Care 2011;34:1683-8.
5. Persson B, Hansson U. Hypoglycaemia in pregnancy. Baillieres Clin Endocrinol Metab 1993;7:731-9.
6. Kitzmiller JL, Block JM, Brown FM, et al. Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care. Diabet Care 2008;31:1060-79.
7. ACOG Committee on Practice Bulletins-Gynecology. ACOG Practice Bulletin No. 60: pregestational diabetes mellitus. Obstet Gynecol 2005;105:675-85.
8. Ringholm L, Pedersen-Bjergaard U, Thorsteinsson B, et al. Hypoglycemia in pregnant women with type 1 diabetes: clinical features and management. Diabet Hypoglycemia 2011;3:3-7.
9. Holleman F, Schmitt H, Rottiers R, et al. Reduced frequency of severe hypoglycemia and coma in well-controlled IDDM patients treated with insulin lispro. The Benelux-UK Insulin Lispro Study Group. Diabet Care 1997;20:1827-32.
10. Heller S, Damm P, Mersebach H, et al. Hypoglycemia in type 1 diabetic pregnancy: the role of preconception insulin aspart treatment in a randomized study. Diabet Care 2010;33:473-7.
11. Keating GM. Insulin detemir: a review of its use in the management of diabetes mellitus. Drugs 2012;72:2255-87.
12. Durnwald CP, Landon MB. Insulin analogues in the management of the pregnancy complicated by diabetes mellitus. Curr Diab Rep 2011;11:28-34.
13. Wyatt JW, Frias JL, Hoyme HE, et al. Congenital anomaly rate in offspring of mothers with diabetes treated with insulin lispro during pregnancy. Diabet Med 2005;22:803-7.
14. Mathiesen ER, Kinsley B, Amiel SA, et al. Maternal glycemic control and hypoglycemia in type 1 diabetic pregnancy: a randomized trial of insulin aspart versus human insulin in 322 pregnant women. Diabet Care 2007;30:771-6.
15. Hod M, Damm P, Kaaja R, et al. Fetal and perinatal outcomes in type 1 diabetes pregnancy: a randomized study comparing insulin aspart with human insulin in 322 subjects. Am J Obstet Gynecol 2008;198:186-e1-7.
16. Guerci B, Sauvanet JP. Subcutaneous insulin: pharmacokinetic variability and glycemic variability. Diabet Metab 2005;31:4S7-24.
17. Trujillo AI. Insulin analogs and pregnancy. Diabetes Spectr 2007; 20:94-101.
18. Lepore M, Pampanelli S, Fanelli C, et al. Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro. Diabetes 2000;49:2142-8.
19. Heise T, Nosek L, Ronn BB, et al. Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes. Diabetes 2004;53: 1614-20.
20. Garg S, Moser E, Dain MP, Rodionova A. Clinical experience with insulin glargine in type 1 diabetes. Diabetes Technol Ther 2010;12: 835-46.
21. Heise T, Pieber TR. Towards peakless, reproducible and longacting insulins. An assessment of the basal analogues based on isoglycaemic clamp studies. Diabetes Obes Metab 2007;9: 648-59.
22. Plank J, Bodenlenz M, Sinner F, et al. A double-blind, randomized, dose-response study investigating the pharmacodynamic and pharmacokinetic properties of the long-acting insulin analog detemir. Diabetes Care 2005;28:1107-12.
23. Mathiesen ER, Hod M, Ivanisevic M, et al. Maternal efficacy and safety outcomes in a randomized, controlled trial comparing insulin detemir with NPH insulin in 310 pregnant women with type 1 diabetes. Diabetes Care 2012;35:2012-17.
24. Hod M, Mathiesen ER, Jovanovič L, et al. A randomized trial comparing perinatal outcomes using insulin detemir or neutral protamine Hagedorn in type 1 diabetes. J Matern Fetal Neonatal Med 2014;27:7-13.
25. Zhelyazkova-Savova M. Drug therapy for diabetes mellitus during pregnancy and breastfeeding in the beginning of 21 century: status quo and new challenges. Article in Bulgarian. Akusherstvo i Ginekologija 2012;51:36-40.
26. Yogev Y, Chen R, Ben-Haroush A, et al. Continuous glucose monitoring for the evaluation of gravid women with type 1 diabetes mellitus. Obstet Gynecol 2003;101:633-8.
27. Murphy HR, Rayman G, Lewis K, et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ 2008;337:a1680.
28. Secher AL, Ringholm L, Andersen HU, et al. The effect of realtime continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial. Diabet Care 2013;36: 1877-83.
29. Blevins TC, Bode BW, Garg SK, et al. Statement by the American Association of Clinical Endocrinologists Consensus Panel on continuous glucose monitoring. Endocr Pract 2010;16: 730-45.
30. Golden SH, Sapir T. Methods for insulin delivery and glucose monitoring in diabetes: summary of a comparative effectiveness review. J Manag Care Pharm 2012;18:1-17.
31. Wender-Ozegowska E, Zawiejska A, Ozegowska K, et al. Multiple daily injections of insulin versus continuous subcutaneous insulin infusion for pregnant women with type 1 diabetes. Aust N Z J Obstet Gynaecol 2013;53:130-5.
32. Bergenstal RM, Tamborlane WV, Ahmann A, et al. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med 2010;363:311-20.
33. Petrovski G, Dimitrovski C, Bogoev M, et al. Is there a difference in pregnancy and glycemic outcome in patients with type 1 diabetes on insulin pump with constant or intermittent glucose monitoring. A pilot study. Diabetes Technol Ther 2011;13:1109-13.